CB
Colossal BiosciencesColossal Biosciences is a genetic engineering company working to de-extinct species like the woolly mammoth and dire wolf while commercializing spinout biotech applications.
2 Pulse stories
ST
Scribe TherapeuticsClinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.
5 Pulse stories
Total Raised
$850M
Colossal BiosciencesScribe Therapeutics
Last Valuation
$10.3B
Colossal BiosciencesScribe Therapeutics
Biotech
Sector
Biotech
2021
Founded
2018
Dallas, Texas
HQ
Alameda, California
Private
Status
Public (SCTX)
Colossal Biosciences investors
TWG GlobalThomas TullMark WalterTim DraperWinklevoss CapitalIn-Q-TelARCH Venture PartnersTom Brady
Scribe Therapeutics investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Colossal Biosciences and Scribe Therapeutics.